Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
European Journal of Clinical Pharmacology
|
March 15, 2019
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population
Anaïs Glatard, Monia Guidi, Maria Dobrinas, et al.
Clinical Pharmacokinetics
|
May 26, 2025
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of Acromegaly
Anaïs Glatard, Sofia Friberg-Hietala, Lina Keutzer, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2015
Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients
Anaïs Glatard, Laurent Bourguignon, Roger W Jelliffe, et al.
Experimental and Clinical Psychopharmacology
|
October 20, 2017
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy
Anaïs Glatard, Maria Dobrinas, Mehdi Gholamrezaee, et al.
Toxicology and Applied Pharmacology
|
August 2, 2015
Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug development
Anaïs Glatard, Aliénor Berges, Tarjinder Sahota, et al.
Clinical and Translational Science
|
November 27, 2024
Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia
Pavan Vaddady, Anaïs Glatard, Giovanni Smania, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 18, 2021
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population
Aurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Clinical Pharmacokinetics
|
September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses
Anaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.
British Journal of Clinical Pharmacology
|
May 31, 2019
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment
Perrine Courlet, Monia Guidi, Anaïs Glatard, et al.
Pharmacogenetics and Genomics
|
September 26, 2017
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs
Aurélie Delacrétaz, Patricia Lagares Santos, Nuria Saigi Morgui, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
European Journal of Clinical Pharmacology
|
March 15, 2019
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population
Anaïs Glatard, Monia Guidi, Maria Dobrinas, et al.
Clinical Pharmacokinetics
|
May 26, 2025
Population Pharmacokinetic Analysis of an Octreotide Depot (CAM2029) in the Treatment of Acromegaly
Anaïs Glatard, Sofia Friberg-Hietala, Lina Keutzer, et al.
Antimicrobial Agents and Chemotherapy
|
March 11, 2015
Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patients
Anaïs Glatard, Laurent Bourguignon, Roger W Jelliffe, et al.
Experimental and Clinical Psychopharmacology
|
October 20, 2017
Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy
Anaïs Glatard, Maria Dobrinas, Mehdi Gholamrezaee, et al.
Toxicology and Applied Pharmacology
|
August 2, 2015
Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug development
Anaïs Glatard, Aliénor Berges, Tarjinder Sahota, et al.
Clinical and Translational Science
|
November 27, 2024
Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia
Pavan Vaddady, Anaïs Glatard, Giovanni Smania, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 18, 2021
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population
Aurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Clinical Pharmacokinetics
|
September 26, 2019
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses
Anaïs Glatard, Monia Guidi, Aurélie Delacrétaz, et al.
British Journal of Clinical Pharmacology
|
May 31, 2019
Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment
Perrine Courlet, Monia Guidi, Anaïs Glatard, et al.
Pharmacogenetics and Genomics
|
September 26, 2017
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs
Aurélie Delacrétaz, Patricia Lagares Santos, Nuria Saigi Morgui, et al.
Page
of 2